NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that, after a successful beta test, its CombiMatrix group’s subsidiary, CombiMatrix Molecular Diagnostics (CMDX), has launched its innovative, Bacterial Artificial Chromosome (BAC) array Comparative Genomic Hybridization (CGH) Technical Only Program (TOP) for reference laboratories and other clients. Two laboratories have established partnerships with CMDX under TOP.
